Cipher Pharmaceuticals
6560 Kennedy Road
Mississauga
Ontario
L5T 2X4
Canada
Tel: 905-565-0043
Fax: 905-565-1776
235 articles about Cipher Pharmaceuticals
-
Cipher Pharma Nabs INNOCTIS and Experienced U.S. Sales Force for $45 Million Cash
4/13/2015
-
Cipher Pharmaceuticals Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis
3/23/2015
-
Can-Fite BioPharma Signs Multi-Million Dollar Distribution Agreement For CF101 In Canada With Cipher Pharmaceuticals
3/23/2015
-
Cipher Pharmaceuticals To Present At Cowen and Company Health Care Conference 2015
2/26/2015
-
Cipher Pharmaceuticals Acquires Three Products From Astion Pharma
2/26/2015
-
Cipher Pharmaceuticals Reports Financial Results For Fiscal 2014
2/25/2015
-
Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By Health Canada
2/12/2015
-
Cipher Pharmaceuticals To Present At BIO CEO & Investor Conference 2015
2/9/2015
-
Notice Of Cipher Pharmaceuticals Q4 And Year-End 2014 Conference Call
2/3/2015
-
Cipher Pharmaceuticals Appoints Lynne Bulger As Vice President, Medical Affairs
1/19/2015
-
Cipher Pharmaceuticals Acquires Assets Of Melanovus Oncology Inc.
1/9/2015
-
Cipher Pharmaceuticals Acquires Canadian Commercialization Rights To Novel Antibacterial Compound Ozenoxacin
1/7/2015
-
Cipher Pharmaceuticals Announces Adoption Of Advance Notice By-Law
12/18/2014
-
Cipher Pharmaceuticals To Ring The Nasdaq Stock Market Opening Bell
12/5/2014
-
Cipher Pharmaceuticals To Present At Piper Jaffray Healthcare Conference 2014
11/25/2014
-
Cipher Pharmaceuticals To Commence Trading On The NASDAQ Global Market
11/20/2014
-
FDA Chides Cipher Pharmaceuticals Over Cholesterol Drug Ad's Superiority Claims
9/22/2014
-
Cipher Pharmaceuticals To Present At Rodman & Renshaw 16th Annual Global Investment Conference
9/3/2014
-
Shawn Patrick O’Brien, President & CEO Of Cipher Pharmaceuticals On BNN
8/21/2014
-
Cipher Pharmaceuticals And Ranbaxy Laboratories Announce Distribution Agreement For Isotretinoin Product In Brazil
7/24/2014